CHOONG CHOON HAU

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

TITAN PHARMACEUTICALS INC

Filing Date Source Excerpt
2023-11-28 This information is based solely on a Schedule 13 D filed by Choong Choon Hau on July 20, 2023. In addition, in August 2023, we issued a convertible promissory note to Mr. Hau, all or part of which can be converted into our common stock at a conversion price of $0.5712 per share from time to time following the issuance date and ending on the maturity date.

Data sourced from SEC filings. Last updated: 2025-10-12